The effect of creatine and coenzyme q10 combination therapy on mild cognitive impairment in Parkinson's disease.

European Neurology
Zhenguang LiXiaohua Ju

Abstract

To investigate the effect of creatine and coenzyme Q10 (CoQ10) combination therapy on mild cognitive impairment (MCI) in Parkinson's disease (PD; PD-MCI) and its influences on plasma phospholipid (PL) levels in PD-MCI. The demographic data of 75 PD-MCI patients who enrolled in this collaborative PD study were collected. These patients were evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) III and the Montreal Cognitive Assessment (MoCA). These 75 PD-MCI patients were randomly treated with creatine monohydrate 5 g b.i.d. and CoQ10 100 mg t.i.d. orally or placebo. MoCA evaluation and PL level measurements were performed after 12 and 18 months of treatment. After 12 and 18 months of treatment, the differences in the MoCA scores of the combination therapy and control groups were statistically significant (p < 0.05 at 12 months and p < 0.01 at 18 months), and the plasma PL levels of the combination therapy group were significantly lower than those of the control group (p < 0.01 at 12 months and p < 0.001 at 18 months). Combination therapy with creatine and CoQ10 could delay the decline of cognitive function in PD-MCI patients and could lower their plasma PL levels; therefore, this combination therapy may have a ne...Continue Reading

Citations

Jan 11, 2016·Amino Acids·Andreas Bender, Thomas Klopstock
Feb 18, 2016·Oxidative Medicine and Cellular Longevity·Valerio ChiurchiùMauro Maccarrone
Mar 25, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Irene LitvanDag Aarsland
Sep 22, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Elvira Valera, Eliezer Masliah
Jun 13, 2019·CNS & Neurological Disorders Drug Targets·Kajal Rajdev, Sidharth Mehan
Apr 10, 2020·Parkinson's Disease·Congcong FangBaohui Liu
Dec 14, 2018·The Egyptian Journal of Neurology, Psychiatry and Neurosurgery·Ehab Ragaa AbdelraoufNeveen Hassan Nashaat
May 10, 2019·Neurotoxicity Research·Eduardo Peil Marques, Angela T S Wyse
Nov 26, 2016·Oxidative Medicine and Cellular Longevity·Haifeng LiZebo Huang
Feb 23, 2021·Journal of Neurochemistry·Dennison TrinhJoanne E Nash
Apr 4, 2021·Nutrients·Holly ClarkeMichael J Ormsbee
Jun 3, 2021·Nutrients·Kylie K HarmonMatt S Stock
Jul 3, 2021·Nature Reviews. Disease Primers·Dag AarslandDaniel Weintraub
Aug 28, 2018·Chemical Reviews·Saba ParvezYimon Aye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.